Malignant Brain Tumor
📧 Sign up to get email alerts when something new happens for Malignant Brain Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: A Study of ABM-1310 in Patients With BRAF V600-Mutant Relapsed and Drug Resistant Primary Malignant Brain Tumors [Phase 1]
A Phase 1 trial of ABM-1310 for BRAF V600-mutant relapsed and drug-resistant primary malignant brain tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors [Phase 1, Phase 2]
Clinical trial updates the evaluation of an IDO inhibitor in combination with temozolomide for adult malignant brain tumors, including gliob…
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children [Phase 2]
Phase 2 pilot study of cabozantinib for recurrent or progressive central nervous system tumors in children has been terminated; results were…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects [Phase 2]
Phase 2 trial evaluating combination of an oncolytic adenovirus with pembrolizumab for brain cancers has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer [NA]
The clinical trial investigating a computer-based intervention for distance caregivers of parents with advanced cancer has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-01-09Clinical Trial Update: Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE) [Phase 2]
Phase 2 imaging study of XERECEPT for peritumoral brain edema and brain tumors has been terminated.